Semester |
Code No. |
Course Title |
Credit Hours |
Exam. Hours |
Exam. Marks |
Written |
Oral* |
Written |
Oral |
First |
2902 |
Clinical Pharmacokinetics. |
[4] |
3 |
1 |
160 |
40 |
1901 |
Pharmacy Practice (I). |
[3] |
3 |
1 |
120 |
30 |
1902 |
Infectious Disease Therapeutics. |
[2] |
2 |
1 |
80 |
20 |
1903 |
GIT Therapeutics. |
[2] |
2 |
1 |
80 |
20 |
1904 |
Pharmaceutical Care for Patients With Immunological Disorders. |
[2] |
2 |
1 |
80 |
20 |
1905 |
Pharmaceutical Care for Patients With Endocrine Disorders. |
[2] |
2 |
1 |
80 |
20 |
1906 |
Oncology Therapeutics. |
[3] |
3 |
1 |
120 |
30 |
Second |
1907 |
Bases of Therapeutic Literature Evaluation and Biostatistics. |
[3] |
3 |
1 |
120 |
30 |
1908 |
Pharmacy Practice (II). |
[3] |
3 |
1 |
120 |
30 |
1909 |
Pharmaceutical Care for Patients With Cardiovascular Disorders. |
[3] |
3 |
1 |
120 |
30 |
1910 |
Pharmaceutical Care for Patients With Structural or Neurological Disorders. |
[3] |
3 |
1 |
120 |
30 |
1911 |
Pharmaceutical Care for Patients With Renal Disorders. |
[3] |
3 |
1 |
120 |
30 |
1912 |
Pharmaceutical Care for Patients With Respiratory Disorders. |
[3] |
3 |
1 |
120 |
30 |
Total credit hours required |
36 |
|
|
|
|
Code No.&Credit Hours |
Course Title and Content |
2902 (4+0) |
Clinical Pharmacokinetics:
Introduction to advanced concept in clinical pharmacokinetics with
emphasis on special patient populations and specific drugs. Drug dosing
to renal impaired patients and patients with liver problems will be of
interest. Mechanisms and kinetics of drug clearance through liver
enzymes and cytochrom P 450 system will be discussed. |
1901 (3+0) | Pharmacy Practice (I):
Pharmacy practice I provides fundamental understanding of functions,
responsibities, and outcomes of pharmacy practice in modern health care
system. Introducing fundamental concepts of pharmaceutical care and
patient counseling with emphasis on communication skills, patient
interview and medical history documentation. The course will give
special interst for special patient groups [geriatric, pediatric, etc….]
The course also introduces the basic techniques of physical assessment.
Student will apply their medical information on several patient eases
and therapeutic plans through problem based learning technique. |
1902 (2+0) |
Infectious Disease Therapeutics:
Introduces different antibiotics, antifungal and antiviral therapy. Case
discussion incorporated for various disease states, with emphasis on
drug interactions, adverse drug reactions, dosing monitoring and patient
counseling. |
1903 (2+0) |
GIT Therapeutics:
Provides fundamental understanding of gastrointestinal tract and
pathophysiology of different diseases. Topics include conditions such as
peptic ulcer, irritable bowel syndrome, gastrointestinal reflux disease
and drug induce peptic ulcers will be discussed through the course with
emphasis on therapeutic option and significant drug interaction and
patient counseling. |
1904 (2+0) |
Pharmaceutical Care for Patients With Immunological Disorders:
Pathysiology / pharmacotherapy of common immunological disorders. Topics
include conditions such as autoimmune diseases such as rheumatic
disease, diabetes mellitus, addison's disease, AIDS, hepatitis
pernicious anaemia, mephitis, vitiligo, multiple sclerosis. |
1905 (2+0) |
Pharmaceutical Care for Patients With Endocrine Disorders:
The concepts of pharmaceutical with care are applied in an integrated
manner with clinical sciences for patients with endocrine disorders.
Topics include conditions such as diabetes mellitus; hyperthyroidism and
hypothyroidism will be discussed in details with emphasis on therapeutic
choices, drug interaction, therapeutic monitoring and patient
counseling. |
1906 (3+0) |
Oncology Therapeutics:
Provides understanding of basic principles of oncology. Topics such as
breast cancer, leukemia and liver cancer will be discussed with emphasis
on therapeutic choices, side effects, therapeutic monitoring, drug
interaction and patient counseling. Nutritional support and
psychological state of the cancer patients will be also introduced in
brief. |
1907 (3+0) |
Bases of Therapeutic Literature Evaluation and Biostatistics:
Provides the basic information about literature criticism and how to
evaluate information through certain scientific criteria. Basic
biostatistics with regard to clinical trials using case study analysis.
Introducing experimental design for clinical studies and methods of
analysis in each design. |
1908 (3+0) |
Pharmacy Practice (II):
Pharmacy practice II provides information about OTC drug and the most
common OTC products in the market with regard to the different body
system. The course will discuss the condition, the OTC product and the
required or desired outcome for this condition and the monitoring
parameters and follow up timing with special interest in the important
points that should be mentioned during patient counseling for each
product (if any). |
1909 (3+0) |
Pharmaceutical Care for Patients With Cardiovascular Disorders:
Provides basic information about circulatory system and pathophysiology
of circulatory disorders. Topics such as hypertension, lipid disorders,
cerebral and peripheral vascular disorders as well as anticoagulation
will be of main interest in the course regarding pharmacotherapeutic
choices and rationale for each choice. |
1910 (3+0) |
Pharmaceutical Care for Patients With Structural or Neurological Disorders:
Provides information about pathophysiology and pharmacotherapeutic
choices to treat condition affecting structure such as osteoporosis,
arthritis, and osteomyelitis and conditions affecting the nervous system
such as pain, headache, migraine and Parkinsonism. |
1911 (3+0) |
Pharmaceutical Care for Patients With Renal Disorders:
The concepts of pharmaceutical care are applied in an integrated manner
with pharmaceutical and clinical sciences for patients with renal
disorders. Topics include acute and chronic glomerulonephritis, urinary
tract infections, drug induced renal disorders, acute and chronic renal
failure and drug dosing in renally impaired patients. |
1912 (3+0) |
Pharmaceutical Care for Patients With Respiratory Disorders:
The concepts of pharmaceutical care are applied in an integrated manner
with pharmaceutical and clinical sciences for patients with respiratory
disorders. Topics including conditions such as asthma, chronic
obstructive pulmonary disease, pneumonia, and lung cancer will be
discussed through the course regarding the pathophysiology and
therapeutic choices. |